A5048153679- Gastric Cancer Management and Outcomes
- Gut microbiota and health
- Helicobacter pylori-related gastroenterology studies
- Behavioral Health and Interventions
- Gastrointestinal disorders and treatments
- Metastasis and carcinoma case studies
- Physical Activity and Health
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Ferroptosis and cancer prognosis
- Gastrointestinal motility and disorders
- Thyroid Cancer Diagnosis and Treatment
- Obesity, Physical Activity, Diet
- Gastrointestinal Tumor Research and Treatment
- Bone Metabolism and Diseases
Sun Yat-sen University Cancer Center
2021-2025
Second Affiliated Hospital of Harbin Medical University
2025
Harbin Medical University
2025
State Key Laboratory of Oncology in South China
2025
Sun Yat-sen University
2021-2024
Nanjing Drum Tower Hospital
2023
Abstract Lymph node (LN) metastasis is known as one of the most important prognostic factors for early gastric cancer (EGC) patients. Patients without LNM normally have better prognosis. However, there no evaluation criteria to accurately assess possibility LN metastasis. Therefore, this study aims establish an effective nomogram prognosis prediction. In study, 285 EGC patients from January 2010 December 2015 were enrolled. Pearson’s Chi-Square ( χ 2 ) test (including continuity correction...
Background Papillary thyroid carcinoma coexisting with rheumatoid arthritis is frequently observed in clinical patients, yet its pathogenesis has not been fully elucidated. This investigation sought to further explore the molecular underpinnings of these two diseases. Methods Gene expression profiles for papillary and patients were obtained from Comprehensive Expression Database (GEO). Following discovery shared differentially expressed genes (DEGs) between conditions, three separate...
e16108 Background: Treatment options for Borrmann Type 4 gastric cancer (Linitis Plastica) have long been a topic of debate. This patient group is characterized by diffuse infiltration throughout the stomach, early metastasis, and poor prognosis. In this study, we aim to evaluate efficacy safety combining immunotherapy with chemotherapy patients (B-IV) or large 3 (B-III) cancer. Methods: Patients (pts) diagnosed adenocarcinoma (B-IV B-III) without distant metastasis were eligible study....
For patients with gastrointestinal stromal tumors (GISTs) and liver metastases, there is still debate about whether radiofrequency ablation (RFA) or hepatectomy preferable. The present study aimed to compare the clinical outcomes of RFA in GISTs metastases. retrospective consisted a cohort 43 who had been diagnosed metastases from between January 2010 December 2022. included 18 received combined tyrosine kinase inhibitor (TKI) therapy (RFA group) 25 underwent TKI (hepatectomy group)....